secwatch.observer — SEC 8-K summary
======================================

Issuer:     COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK:        0001267565
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0001104659-23-116013
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Collegium executes $25M accelerated share repurchase; initial delivery of 865K shares
--------------------------------------------------------------------------------

- Executed ASR with Jefferies LLC to repurchase $25M of Collegium common stock.
- Initial delivery of ~865,426 shares based on $23.11 closing price (Nov 8, 2023), ~80% of expected total.
- Final settlement expected in Q4 2023; shares outstanding ~33.1M as of Sep 30, 2023.
- Part of $100M share repurchase program authorized by Board in January 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1267565/000110465923116013/0001104659-23-116013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1267565/000110465923116013/tm2330291d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-116013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer